The trademark application ODYSSEY THERAPEUTICS was filed by Odyssey Therapeutics, a U.S. corporation (the "Applicant"). The application was published for oppositions on December 4, 2022, and it was registered by office on March 13, 2023 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on April 29, 2024.
Goods And Services
The mark was filed in class 5 with Pharmaceutical products and preparations for the treatment of cancer and auto-immune diseases and Molecules used as a component in pharmaceutical preparations for the treatment of cancer and auto-immune diseases..
The mark was filed in class 42 with Providing medical and scientific research information in the fields of pharmaceuticals, clinical trials, cancer, and auto-immune diseases and development of molecules for use by others in developing and designing pharmaceutical products and preparations for the treatment of cancer and auto-immune diseases..